Search Results

There are 90691 results for: content related to: Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients

  1. You have full text access to this OnlineOpen article
    Clinical Outcomes in Kidney Transplant Recipients Receiving Long-Term Therapy With Inhibitors of the Mammalian Target of Rapamycin

    American Journal of Transplantation

    Volume 12, Issue 2, February 2012, Pages: 379–387, F. Cortazar, M. Z. Molnar, T. Isakova, M. E. Czira, C. P. Kovesdy, D. Roth, I. Mucsi and M. Wolf

    Article first published online : 4 NOV 2011, DOI: 10.1111/j.1600-6143.2011.03826.x

  2. You have full text access to this OnlineOpen article
    Do wound complications or lymphoceles occur more often in solid organ transplant recipients on mTOR inhibitors? A systematic review of randomized controlled trials

    Transplant International

    Volume 24, Issue 12, December 2011, Pages: 1216–1230, Liset H. M. Pengel, Liang Q. Liu and Peter J. Morris

    Article first published online : 29 SEP 2011, DOI: 10.1111/j.1432-2277.2011.01357.x

  3. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 12, Issue 6, June 2014, Pages: 480–488, Mareike Alter, Imke Satzger, Harald Schrem, Alexander Kaltenborn, Alexander Kapp and Ralf Gutzmer

    Article first published online : 12 MAY 2014, DOI: 10.1111/ddg.12355

  4. You have full text access to this OnlineOpen article
    mTOR inhibition: the learning curve in kidney transplantation

    Transplant International

    Volume 23, Issue 5, May 2010, Pages: 447–460, Matthew R. Weir, Fritz Diekmann, Stuart M. Flechner, Yvon Lebranchu, Didier A. Mandelbrot, Rainer Oberbauer and Barry D. Kahan

    Article first published online : 3 FEB 2010, DOI: 10.1111/j.1432-2277.2010.01051.x

  5. You have open access to this content
    Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer

    Cancer Science

    Volume 100, Issue 12, December 2009, Pages: 2402–2410, Taro Matsuzaki, Masakazu Yashiro, Ryoji Kaizaki, Koichi Yasuda, Yosuke Doi, Tetsuji Sawada, Masaichi Ohira and Kosei Hirakawa

    Article first published online : 18 AUG 2009, DOI: 10.1111/j.1349-7006.2009.01315.x

  6. Mammalian target of rapamycin (mTOR) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes

    BJU International

    Volume 113, Issue 3, March 2014, Pages: 376–382, Bradley J. Atkinson, Diana H. Cauley, Chaan Ng, Randall E. Millikan, Lianchun Xiao, Paul Corn, Eric Jonasch and Nizar M. Tannir

    Article first published online : 2 DEC 2013, DOI: 10.1111/bju.12420

  7. You have full text access to this OnlineOpen article
    CMV Late Phase-Induced mTOR Activation Is Essential for Efficient Virus Replication in Polarized Human Macrophages

    American Journal of Transplantation

    Volume 12, Issue 6, June 2012, Pages: 1458–1468, M. Poglitsch, T. Weichhart, M. Hecking, J. Werzowa, K. Katholnig, M. Antlanger, A. Krmpotic, S. Jonjic, W. H. Hörl, G. J. Zlabinger, E. Puchhammer and M. D. Säemann

    Article first published online : 5 MAR 2012, DOI: 10.1111/j.1600-6143.2012.04002.x

  8. You have full text access to this OnlineOpen article
    Improved Renal Function After Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation

    American Journal of Transplantation

    Volume 12, Issue 10, October 2012, Pages: 2744–2753, L. Mjörnstedt, S. S. Sørensen, B. von zur Mühlen, B. Jespersen, J. M. Hansen, C. Bistrup, H. Andersson, B. Gustafsson, L.H. Undset, H. Fagertun, D. Solbu and H. Holdaas

    Article first published online : 19 JUL 2012, DOI: 10.1111/j.1600-6143.2012.04162.x

  9. You have full text access to this OnlineOpen article
    Early use of mammalian target of rapamycin inhibitors is an independent risk factor for incisional hernia development after liver transplantation

    Liver Transplantation

    Volume 18, Issue 2, February 2012, Pages: 188–194, Roberto Montalti, Antonio Mimmo, Gianluca Rompianesi, Valentina Serra, Nicola Cautero, Roberto Ballarin, Nicola De Ruvo, Robert Cunningham Gerring, Giorgio Enrico Gerunda and Fabrizio Di Benedetto

    Article first published online : 25 JAN 2012, DOI: 10.1002/lt.22445

  10. Growing experience with mTOR inhibitors in pediatric solid organ transplantation

    Pediatric Transplantation

    Volume 17, Issue 7, November 2013, Pages: 694–706, R. Ganschow, L. Pape, E. Sturm, J. Bauer, M. Melter, P. Gerner, B. Höcker, T. Ahlenstiel, M. Kemper, F. Brinkert, M. M. Sachse and B. Tönshoff

    Article first published online : 4 SEP 2013, DOI: 10.1111/petr.12147

  11. Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing

    British Journal of Dermatology

    Volume 166, Issue 2, February 2012, Pages: 422–424, L. Feldmeyer, G.F.L. Hofbauer, T. Böni, L.E. French and J. Hafner

    Article first published online : 5 DEC 2011, DOI: 10.1111/j.1365-2133.2011.10591.x

  12. You have full text access to this OnlineOpen article
    New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

    Cancer

    Volume 118, Issue 6, 15 March 2012, Pages: 1486–1497, Mark Agulnik

    Article first published online : 11 AUG 2011, DOI: 10.1002/cncr.26361

  13. You have full text access to this OnlineOpen article
    Mechanisms of Everolimus-Induced Glomerulosclerosis After Glomerular Injury in the Rat

    American Journal of Transplantation

    Volume 5, Issue 12, December 2005, Pages: 2849–2861, C. Daniel, L. Renders, K. Amann, E. Schulze-Lohoff, I.A. Hauser and C. Hugo

    Article first published online : 18 NOV 2005, DOI: 10.1111/j.1600-6143.2005.01120.x

  14. mTOR inhibitors radiosensitize PTEN-deficient non-small-cell lung cancer cells harboring an EGFR activating mutation by inducing autophagy

    Journal of Cellular Biochemistry

    Volume 114, Issue 6, June 2013, Pages: 1248–1256, Eun Ju Kim, Jae-Hoon Jeong, Sangwoo Bae, Seongman Kang, Cheol Hyeon Kim and Young-Bin Lim

    Article first published online : 16 APR 2013, DOI: 10.1002/jcb.24465

  15. You have full text access to this OnlineOpen article
    Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma – systematic review and meta-analysis

    Cancer Medicine

    Volume 2, Issue 6, December 2013, Pages: 862–871, Kenya Yamanaka, Marius Petrulionis, Shibo Lin, Chao Gao, Uwe Galli, Susanne Richter, Susanne Winkler, Philipp Houben, Daniel Schultze, Etsuro Hatano and Peter Schemmer

    Article first published online : 22 OCT 2013, DOI: 10.1002/cam4.150

  16. You have full text access to this OnlineOpen article
    The dual PI3K/mTOR inhibitor NVP-BEZ235 and chloroquine synergize to trigger apoptosis via mitochondrial-lysosomal cross-talk

    International Journal of Cancer

    Volume 132, Issue 11, 1 June 2013, Pages: 2682–2693, Christian Seitz, Manuela Hugle, Silvia Cristofanon, Aurélie Tchoghandjian and Simone Fulda

    Article first published online : 4 DEC 2012, DOI: 10.1002/ijc.27935

  17. You have full text access to this OnlineOpen article
    Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors

    Transplant International

    Volume 17, Issue 6, July 2004, Pages: 279–285, Björn Nashan

    Article first published online : 11 MAR 2005, DOI: 10.1111/j.1432-2277.2004.tb00444.x

  18. You have full text access to this OnlineOpen article
    Switch to a Sirolimus-Based Immunosuppression in Long-Term Renal Transplant Recipients: Reduced Rate of (Pre-)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor-Blinded, Controlled Clinical Trial

    American Journal of Transplantation

    Volume 10, Issue 6, June 2010, Pages: 1385–1393, R. Salgo, J. Gossmann, H. Schöfer, H. G. Kachel, J. Kuck, H. Geiger, R. Kaufmann and E. H. Scheuermann

    Article first published online : 1 FEB 2010, DOI: 10.1111/j.1600-6143.2009.02997.x

  19. You have full text access to this OnlineOpen article
    Recurrent hepatocellular carcinoma after liver transplantation – an emerging clinical challenge

    Transplant International

    Volume 26, Issue 2, February 2013, Pages: 109–118, Martin-Walter Welker, Wolf-Otto Bechstein, Stefan Zeuzem and Joerg Trojan

    Article first published online : 21 SEP 2012, DOI: 10.1111/j.1432-2277.2012.01562.x

  20. You have free access to this content
    Does the Use of mTOR Inhibitors Increase Long-Term Mortality in Kidney Recipients?

    American Journal of Transplantation

    Volume 12, Issue 2, February 2012, Pages: 277–278, S. Bunnapradist and K. Kalantar-Zadeh

    Article first published online : 4 NOV 2011, DOI: 10.1111/j.1600-6143.2011.03829.x